Alzheimer's Disease GWAS

Dataset

Download summary statistics

Publications

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.
Jansen IE, et al.
Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9

Dataset phenotypes

  • Alzheimer's disease

Dataset subjects

Cases Controls Cohort Ancestry
2,066 7,637 Psychiatric Genomic Consortium-Alzheimer Workgroup: Norwegian DemGene Network European
322 6,325 Psychiatric Genomic Consortium-Alzheimer Workgroup: TwinGene European
348 779 Psychiatric Genomic Consortium-Alzheimer Workgroup: Swedish Twin Studies of Aging European
17,008 37,154 International Genomics of Alzheimer's Project (IGAP) European
4,343 3163 Alzheimer’s Disease Sequencing Project (ADSP) European
47,793 328,320 UK Biobank European

Ancestry

Experiment summary

This dataset represents a meta-analysis of two Alzheimer’s disease (AD) association analyses. Phase 1 included 24,087 clinically diagnosed late-onset AD cases and 55,058 controls. Phase 2 included 47,793 cases of AD-by-proxy from the UK Biobank and 328,320 controls. AD-by-proxy is defined as individuals having one or two parents with AD; cases with two parents were given greater weight. AD-by-proxy controls had two parents without AD; subjects with older parents were given greater weight.

Dataset ID
GWAS_UKBiobankAD_eu